Altogether, these data support the view that SETD2 is necessary to guide correct transcription termination genome-wide and that mutations in this histone modifier gene cause aberrant transcription patterns in ccRCC. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.